| (E) |   1. | 
¯f¤H67·³¤k©Ê¡A¦í¦w¾i¦Ñ¤H°|¡A¤U§É¶^¶Ë¥k¸}¡A¤¤Ñ«á¦]·NÃѤ£²M¦ñ¦³®ð«P¡Bµo¿N¡B´HŸ(chills)¦Ó¦í°|¡C¯f¤H¦³Ãþ·Àã©ÊÃö¸`ª¢¡A¤]¦³°ª¦åÀ£¦X¨Ö¤ßŦ°IºÜªº¯f¥v¡C¦í°|®É¡AGCS E2V2M3¡FBP¡A112/57 mmHg¡FHR¡A85/min¡Aregular¡FRR¡A25/min¡FÅé·Å¡AÄá¤ó37«×¡F¤ßŦ§e²{³W«ß¡A¦ý¦b¤ß¦y³¡¦³Gr.III/VI Systolic murmur¡F¦bªÍ°ò³B¿BÀã©I§lÁn¡F¥|ªÏ¦h³B·ï¦å¡A¦¹¥~©|µL²§±`©Ò¨£¡C¹êÅç«Ç©Ò¨£¡G¥Õ¦å²y¡A15350/£gL¡FC-¤ÏÀ³³J 44.20 mg/dl(¥¿±`<1.9)¡F¦Ù»ÄÓþ 0.98mg/dl¡F¦í°|²Ä¤G¤Ñ¦³¨â®M¦å²G²Óµß°ö¾i§e²{²Äõ¶§©Ê¯fµß¡CÁ{§É¶EÂ_¬°·P¬V©Ê¤ß¤º½¤ª¢(infective
endocarditis)«á¡A½Ð°Ý¦b¦¹¨è¡A¤U¦C¦óºØ³B¸m¬°©y¡H
 | 
| A. | ¶i¦æ¤¶¤J©Ê¤ß¾ÉºÞÀˬd | 
| B. | ¥~¬ì¤â³N¥HÀò±o²Õ´¶EÂ_ | 
| C. | ¨Ï¥Î IV dopamine 0.5 £ggkg/min ª`®g¡A¥H¼W¥[§¿¶q | 
| D. | §@24¤p®É¤ß¹q¹ÏÀˬd¥H½T©w¤ß«ß¤£¾ã | 
| E. | §@¶Wµªi¤ß¹ÏÀˬd¥H½T©w¤ßŦ¯fÅÜ | 
|   | 
| (D) |   2. | 
²Óµß©ÊªÍª¢¦X¨Ö¦Ø½¤¿n²G¡A¤U¦C¦óºØ¦Ø½¤¿n²G¤§¼Æ¾Úªí¥Ü¶·´¡¯ÝºÞ¤Þ¬y¡H
 | 
| A. | PMN > 90% | 
| B. | WBC > 1000/mm3 | 
| C. | Glucose < 100 mg/dL | 
| D. | pH < 7.2 | 
| E. | LDH > 300 IU/L | 
|   | 
| (E) |   3. | 
¤U¦C¦³Ãöpancreatic neuroendocrine tumor¤§±Ôz¡A¦óªÌ¥¿½T¡H (1)glucagonoma¥i¯à¾ÉP¿}§¿¯f (2)VIPoma (VIP: vasoactive intestinal peptide)¥i¯à¾ÉPpeptic ulcers (3)insulinoma±`¬°´c©Ê¸~½F (4)EUS (endoscopic ultrasound)¬O°»´ú³oÃþ¸~½F¤§³Ì¨Î¤u¨ã (5) liver metastasis¹ï±wªÌ¤§¹w«á¼vÅT¬Æ¤j
 | 
| A. | (1)+(2)+(3) | 
| B. | (2)+(3)+(4) | 
| C. | (3)+(4)+(5) | 
| D. | (2)+(3)+(5) | 
| E. | (1)+(4)+(5) | 
|   | 
| (B) |   4. | 
¤@¦ì24·³¤k©Ê¡A¹L¥hµL¯f¥v¡C¬ù2Ó¤ë«e¶}©lª`·N¥X²{¤ô¸~¡AÅ髦b2Ӥ뤺¼W¥[8¤½¤ç¡C¹êÅç«ÇÀˬd: albumin 2.8 g/dL, creatinine 0.8 mg/dL, t-Chol 280 mg/dL, LDL 163 mg/dL, urine protein-creatinine (P/C) ratio ¬ù9 mg/mg, urinalysis O.B. (-), serum [K] 4 mEq/L, [Ca] 9.2 mg/dL, Hb 12 g/dL¡C¥»¯f¤Hªº¶EÂ_¡A³Ì¥i¯à¬°?
 | 
| A. | IgA nephropathy | 
| B. | minimal change disease | 
| C. | multiple myeloma with nephropathy | 
| D. | systemic lupus erythromatous (SLE) with nephropathy | 
| E. | membranoproliferative glomerulonephritis (MPGN) | 
|   | 
| (E) |   5. | 
¦³Ãö¬y·P¬Ì]±µºØ°Æ§@¥Î»P¸T§Ò¯g¤§±Ôz¡A¤U¦C¦óªÌ¥¿½T¡H (1)¹ïÂû³JÄY«¹L±ÓªÌ¬°±µºØ¬y·P¬Ì]¤§¸T§Ò¡C (2)°£¤F¬ü°ê1976¦~H1N1½Þ¬y·P¬Ì]¥~¡A±µºØ©u¸`¬y·P¬Ì]«áµo¥ÍGuillain-Barre syndrome¤§¾÷²v·¥§C¡C (3)¤p©ó6Ӥ뤧À¦¨à¤£©y±µ¨ü¬y·P¬Ì]¬I¥´¡C (4)³¡¤À¬y·P¬Ì]¤¤§t¦³¥Ò°ò¨E»P¤A°ò¨E¥Î¥H«O¦s¬Ì]¡A¥Ò°ò¨E»P¤A°ò¨E§¡¥i¬°¤HÅé©Ò¥NÁ¡C (5)¦b§PÂ_¬y·P¬Ì]±µºØ«á¤£¨}¨Æ¥ó»P¬Ì]±µºØ¤§¦]ªGÃö«Y®É¡A¸Ó¤£¨}¨Æ¥ó¤§¦º¤`©Î«¯g¤ñ²v¬O«nªºÆ[¹î«ü¼Ð¡C
 | 
| A. | (1)+(2)+(3) | 
| B. | (1)+(2)+(4) | 
| C. | (1)+(3)+(4) | 
| D. | (1)+(3)+(5) | 
| E. | (1)+(2)+(3)+(5) | 
|   | 
| (D) |   6. | 
45·³¤k©Ê¦]«å¡BµL¤O¡B«K¯µ¡BÅ髼W¥[¨Ó¶E¡A¨ÅéÀˬdµo²{¨°ª160¤½¤À¡BÅé«60¤½¤ç¡BÁy³¡²¤¬°¯B¸~¡B»a¥Õ¡A¦åÀ£ 146/92 mmHg¡BPR 58/min¡A regular ©â¦åÀˬdµo²{¶º«e¦å¿}100 mg/dl¡BÁx©T¾J 260 mg/dl¡B§C±K«×Áx©T¾J 160 mg/dl¡ANa 128 mM¡BK 4.0 mM¡BCK 1500 U/L¡A¤U¦C³B¸m¦óªÌ³Ì«ê·í¡J
 | 
| A. | µ¹¤©statinªvÀø | 
| B. | µ¹¤©angiotensin receptor blocker  | 
| C. | ´úUrine sodium¡Bprotein | 
| D. | ´ú¦å¤¤ free T4¡BhsTSH | 
| E. | ´ú¦å¤¤ ACTH¡Bcortisol  | 
|   | 
| (D) |   7. | 
¤U¦C¨º¤@¶µ«D¶EÂ_²Ä1«¬¿}§¿¯fªº¥²n±ø¥ó¡J
 | 
| A. | ªÅ¸¡¦å²MC-Ð`úT¿@«× < 0.5 ng/ml | 
| B. | ¤É¿}¯À¨ë¿E«á6¤ÀÄÁ¦å²MC-Ð`úT¿@«× < 1.8 ng/ml | 
| C. | ¤É¿}¯À¨ë¿E¸ÕÅç6¤À»P0¤À¦å²MC-Ð`úT¿@«×¬Û®t < 0.7 ng/ml | 
| D. | ¿}§¿¯f଻Ĥ¤¬r | 
| E. | Anti-GAD65 ¶§©Ê | 
|   | 
| (A) |   8. | 
50·³¤§¨k¯f¤H,¿©±wµh·¥Û©ÊÃö¸`ª¢(tophaceous gout)¤w1¦~¦h,¨â¤UªÏ¦³³\¦h¤j¤p¤£¤@ªºµh·¥Û(tophi);¦P®É¦³ºC©ÊµÇ¥\¯à¤£¥þ,¦å¤¤creatinineȬ°2.5 mg/ml,¨Ã¦³µÇµ²¥Û.¨äHLA-B5801°ò¦]¬°¶§©Ê.½Ð°Ý³Ì¦X¾Aªº°§¿»ÄÃĪ«¬°¦ó?
 | 
| A. | febuxostat | 
| B. | probenecid | 
| C. | benzbramarone | 
| D. | sulfinpyrazone | 
| E. | allopurinol | 
|   | 
| (A) |   9. | 
¤@¦ì27·³ªº¨k©Ê¡A±q¤p´N¦³¤¤µ¥«×«ùÄò«¬ªº¹L±Ó©Ê»óª¢(Allergic rhinitis)¡A¨ä¦å¤¤total IgE 325IU/ml¡A¹L±ÓìÀˬdµo²{¹ïhouse dust mite Der.P §e+++¡C½Ð°Ý°£¤Fimmunotherapy¤§¥~¡A¤U¦C¦óªÌ¬°º¿ïÃĪ«?
 | 
| A. | intranasal glucocorticoids spray | 
| B. | moderate dose of oral prednisolone | 
| C. | anti-IgE antibody injection | 
| D. | oral pseudoephedrine | 
| E. | oral H1 antihistamine | 
|   | 
| (A) |  10. | 
¤@¦ì50·³¤k©Ê³Q¶EÂ_¦³portal vein thrombosis¡C©PÃä¦å²GÀˬdµo²{¦³JAK2°ò¦]¬ðÅÜ¡A¦¹¯f¤H³Ì¥i¯à¦³¤U¦C¦óºØ¯e¯f¡H
 | 
| A. | myeloproliferative neoplasm | 
| B. | paroxysmal nocturnal hemoglobinuria | 
| C. | protein S deficiency | 
| D. | protein C deficiency | 
| E. | antithrombin III deficiency | 
|   | 
| (C) |  11. | 
¸~½F¼Ð°O(tumor markers)ªºÀ³¥Î¡A¥i¹B¥Î¦b´c©Ê¸~½FªºªvÀø´Á¶¡¡A§@¬°ªvÀø¦¨®Äªº»²§Uµû¦ô¡C¥H¤U¦UºØ¸~½F¼Ð°O»P¸~½Fªº°t¹ï¡Aþ¨Ç¬O¥¿½Tªº? (1)catecholamines»Ppheochromocytoma (2)calcitonin»Ppapillary cancer of the thyroid (3)human chorionic gonadotropin (hCG)»Pgestational trophoblastic disease (4)£\-fetoprotein»Pgonadal germ cell tumor
 | 
| A. | (1)+(2)+(3) | 
| B. | (1)+(2)+(4) | 
| C. | (1)+(3)+(4) | 
| D. | (2)+(3)+(4) | 
| E. | (1)+(2)+(3)+(4) | 
|   | 
| (C) |  12. | 
¹ï©óÃhºÃ¦³intestinal obstruction¤§±wªÌ¡A¸¡³¡¢æ¥ú·Ó¬Û¡]plain abdomen¡^¥i´£¨Ñ¬Û·í¦³¥Îªº¸ê®Æ¡C¤U¦C¦U¶µ±Ôz¡A¦óªÌ¿ù»~¡H
 | 
| A. | plain abdomen¥Î¨Ó§PÂ_nonstrangulating complete small-bowel obstruction¬Û·í¥i¾a  | 
| B. | partial mechanical small-bowel obstruction»Padynamic ileus¤£¤Ó®e©ö°Ï¤À¡A¦ýcolonic distension¦badynamic ileus³q±`¸û©úÅã  | 
| C. | µÈ¤jªº¤p¸z¤¤¥i¨£air-fluid levels¡A±`±Æ¦C¦¨¡§stepladder¡¨ pattern¡A¤Ö¨£¤º§tªÅ®ðªº¤j¸z¡A³o¨Çµo²{±`¨£©óstrangulating small-bowel obstruction  | 
| D. | YÁ{§É¯gª¬«Ü¹³small intestine obstruction¡A¦ýplain abdomen¬Ý°_¨Ó¥¿±`¡A¦¹®É¦w±Æ¸¡³¡CTÀˬd¦³§U©ó¶EÂ_  | 
| E. | ³Ü¾X¾¯¨ÓÀ°¦£§PÂ_¤p¸zªºªý¶ë³¡¦ì¬O¬Û·í¦w¥þªº  | 
|   |